CD4 and esophagitis: (172), the incidence of esophagitis and the levels of inflammatory factors in the treatment group were significantly lower than those in the control group, while the levels of CD3+ T cells, CD4+ T cells, and the CD4+/CD8+ ratio were significantly increased.